7.48
Cancer Therapeutics
Provides students with an in-depth exploration of how underlying mechanisms of cancer biology informs real-world therapeutic strategies. Students examine key classes of cancer treatments and their modes of action, critically assess preclinical and clinical trial data, and discuss the challenges of drug development — from resistance and toxicity to patient stratification. Highlights emerging therapies, such as immunotherapy and targeted treatments, while addressing the ethical and economic factors that influence clinical decision-making in cancer care. Limited to 20.
Prerequisites & course information
Prereq: Biology (GIR) U (Spring) 3-0-9 units
Sources
- Course catalogue ↗2026–2027